Ozempic, which has a lower dose of 0.5-2 semaglutide, is FDA-approved for diabetes control, while higher-dose semaglutide, Wegovy, is approved for weight loss
While all are approved for obesity treatment, evidence specifically in post-bariatric populations varies considerably
Most people notice appetite suppression within the first week of their initial 2.5mg dose
Although hair loss hasnt been reported from all my clients taking GLP-1s, I would say most of them do experience it and its very common, Anabel Kingsley, consultant trichologist and brand president at Philip Kingsley told Bazaar
The success stories of this 6 week Ozempic weight loss plan serves as a testament to the efficacy of this approach and provides inspiration for others embarking on similar paths toward better health